Assessing in vivo toxicity of graphene materials: Current methods and future outlook

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1565-1580

  Ma, Yufei ^a   Shen, He ^a,b   Tu, Xiaolong ^a,b   Zhang, Zhijun ^a  

^a SUZHOU INSTITUTE OF NANO TECH AND NANO BIONICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

biomedicine; graphene; graphene oxide; in vivo; toxicity

Indexed keywords

GRAPHENE; GRAPHENE OXIDE; HYDROGEN PEROXIDE; NANOMATERIAL; QUANTUM DOT; GRAPHITE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; MAMMAL CELL; MICROORGANISM; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN INTERACTION; REVIEW; SIMULATION; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FORECASTING; PHYSIOLOGY; PROCEDURES; TOXICITY TESTING; TRENDS;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FORECASTING; GRAPHITE; NANOPARTICLES; TOXICITY TESTS;

EID: 84907456395     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.68     Document Type: Review

References (94)

1. Geim AK, Novoselov KS. The rise of graphene. Nat. Mater. 6(3), 183-191 (2007).
2. Geim AK. Random walk to graphene (Nobel Lecture). Angew. Chem. Int. Ed. 50(31), 6966-6985 (2011).
3. Novoselov KS, Geim AK, Morozov S, et al. Electric field effect in atomically thin carbon films. Science 306(5696), 666-669 (2004).
4. Palacios T. Graphene electronics: thinking outside the silicon box. Nat. Nanotechnol. 6(8), 464-465 (2011).
5. Brownson DA, Kampouris DK, Banks CE. An overview of graphene in energy production and storage applications. J. Power Sources 196(11), 4873-4885 (2011).
6. Mueller T, Xia F, Avouris P. Graphene photodetectors for high-speed optical communications. Nat. Photonics 4(5), 297-301 (2010).
7. Pyun J. Graphene oxide as catalyst: application of carbon materials beyond nanotechnology. Angew. Chem. Int. Ed. 50(1), 46-48 (2011).
8. Cohen-Tanugi D, Grossman JC. Water desalination across nanoporous graphene. Nano Lett. 12(7), 3602-3608 (2012).
9. Pumera M. Graphene in biosensing. Mater. Today 14(7), 308-315 (2011).
10. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 42(2), 530-547 (2013).
11. Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine 6(2), 317-324 (2011).
12. Shen H, Zhang L, Liu M, Zhang Z. Biomedical applications of graphene. Theranostics 2(3), 283-294 (2012).
13. Mao HY, Laurent S, Chen W, et al. Graphene: promises, facts, opportunities, and challenges in nanomedicine. Chem. Rev. 113(5), 3407-3424 (2013).
14. He H, Klinowski J, Forster M, Lerf A. A new structural model for graphite oxide. Chem. Phys. Lett. 287(1), 53-56 (1998).
15. Bianco A. Graphene: safe or toxic? The two faces of the medal. Angew. Chem. Int. Ed. 52(19), 4986-4997 (2013).
16. Jastrzebska AM, Kurtycz P, Olszyna AR. Recent advances in graphene family materials toxicity investigations. J. Nanopart. Res. 14(12), 1320-1340 (2012).
17. Bussy C, Ali-Boucetta H, Kostarelos K. Safety considerations for graphene: lessons learnt from carbon nanotubes. Accounts Chem. Res. 46(3), 692-701 (2012).
18. Jachak AC, Creighton M, Qiu Y, Kane AB, Hurt RH. Biological interactions and safety of graphene materials. MRS Bull. 37(12), 1307-1313 (2012).
19. Sanchez VC, Jachak A, Hurt RH, Kane AB. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem. Res. Toxicol. 25(1), 15-34 (2011).
20. Ren H, Wang C, Zhang J, et al. DNA cleavage system of nanosized graphene oxide sheets and copper ions. ACS Nano 4(12), 7169-7174 (2010).
21. Wu M, Kempaiah R, Huang P-JJ, Maheshwari V, Liu J. Adsorption and desorption of DNA on graphene oxide studied by fluorescently labeled oligonucleotides. Langmuir 27(6), 2731-2738 (2011).
22. Zhang L, Wang Z, Lu Z, et al. PEGylated reduced graphene oxide as a superior ssRNA delivery system. J. Mater. Chem. B 1(6), 749-755 (2013).
23. Bao H, Pan Y, Ping Y, et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7(11), 1569-1578 (2011).
24. Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale 3(3), 1252-1257 (2011).
25. Chen B, Liu M, Zhang L, Huang J, Yao J, Zhang Z. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem. 21(21), 7736-7741 (2011).
26. Titov AV, Král P, Pearson R. Sandwiched graphene -membrane superstructures. ACS Nano 4(1), 229-234 (2010).
27. Qin W, Li X, Bian W-W, Fan X-J, Qi J-Y. Density functional theory calculations and molecular dynamics simulations of the adsorption of biomolecules on graphene surfaces. Biomaterials 31(5), 1007-1016 (2010).
28. Tu Y, Lv M, Xiu P, et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat. Nanotechnol. 8(8), 594-601 (2013).
29. Nel AE, Mdler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009).
30. Hu W, Peng C, Lv M, et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5(5), 3693-3700 (2011).
31. Shen H, Liu M, He H, et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl. Mater. Interfaces 4(11), 6317-6323 (2012).
32. Zhang M, Yin B-C, Wang X-F, Ye B-C. Interaction of peptides with graphene oxide and its application for real-time monitoring of protease activity. Chem. Commun. 47(8), 2399-2401 (2011).
33. Lee DY, Khatun Z, Lee J-H, Lee Y-K, In I. Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules 12(2), 336-341 (2011).
34. Kotchey GP, Allen BL, Vedala H, et al. The enzymatic oxidation of graphene oxide. ACS Nano 5(3), 2098-2108 (2011).
35. Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 4(10), 5731-5736 (2010).
36. Liu S, Zeng TH, Hofmann M, et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 5(9), 6971-6980 (2011).
37. Hu W, Peng C, Luo W, et al. Graphene-based antibacterial paper. ACS Nano 4(7), 4317-4323 (2010).
38. Akhavan O, Ghaderi E. Escherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting manner. Carbon 50(5), 1853-1860 (2012).
39. Sawangphruk M, Srimuk P, Chiochan P, Sangsri T, Siwayaprahm P. Synthesis and antifungal activity of reduced graphene oxide nanosheets. Carbon 50(14), 5156-5161 (2012).
40. Sasidharan A, Panchakarla L, Chandran P, et al. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 3(6), 2461-2464 (2011).
41. Nurunnabi M, Khatun Z, Huh KM, et al. In vivo biodistribution and toxicology of carboxylated graphene quantum Dots. ACS Nano 7(8), 6858-6867 (2013).
42. Peng C, Hu W, Zhou Y, Fan C, Huang Q. Intracellular imaging with a grapheme-based fluorescent probe. Small 6(15), 1686-1692 (2010).
43. Liu K, Zhang J-J, Cheng F-F, Zheng T-T, Wang C, Zhu J-J. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J. Mater. Chem. 21(32), 12034-12040 (2011).
44. Huang J, Zong C, Shen H, et al. Mechanism of cellular uptake of graphene oxide studied by surface-enhanced raman spectroscopy. Small 8(16), 2577-2584 (2012).
45. Yue H, Wei W, Yue Z, et al. The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 33(16), 4013-4021 (2012).
46. Mu Q, Su G, Li L, et al. Size-dependent cell uptake of protein-coated graphene oxide nanosheets. ACS Appl. Mater. Interfaces 4(4), 2259-2266 (2012).
47. Mullick Chowdhury S, Lalwani G, Zhang K, Yang JY, Neville K, Sitharaman B. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 34(1), 283-293 (2013).
48. Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res. Lett. 6(8), 1-8 (2011).
49. Tkach AV, Yanamala N, Stanley S, et al. Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small 9(9-10), 1686-1690 (2012).
50. Ryoo S-R, Kim Y-K, Kim M-H, Min D-H. Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano 4(11), 6587-6598 (2010).
51. Park SY, Park J, Sim SH, et al. Enhanced differentiation of human neural stem cells into neurons on graphene. Adv. Mater. 23(36), 263-267 (2011).
52. Li N, Zhang X, Song Q, et al. The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates. Biomaterials 32(35), 9374-9382 (2011).
53. Chen G-Y, Pang D-P, Hwang S-M, Tuan H-Y, Hu Y-C. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 33(2), 418-427 (2012).
54. Shi X, Chang H, Chen S, Lai C, Khademhosseini A, Wu H. Regulating cellular behavior on few-layer reduced graphene oxide films with well-controlled reduction states. Adv. Funct. Mater. 22(4), 751-759 (2012).
55. Akhavan O, Ghaderi E, Emamy H, Akhavan F. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon 54, 419-431 (2013).
56. Chang Y, Yang S-T, Liu J-H, et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 200(3), 201-210 (2011).
57. Liao K-H, Lin Y-S, Macosko CW, Haynes CL. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl. Mater. Interfaces 3(7), 2607-2615 (2011).
58. Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 4(6), 3181-3186 (2010).
59. Wang A, Pu K, Dong B, et al. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J. Appl. Toxicol. 33(10), 1156-1164 (2013).
60. Akhavan O, Ghaderi E, Rahimi K. Adverse effects of graphene incorporated in TiO2 photocatalyst on minuscule animals under solar light irradiation. J. Mater. Chem. 22(43), 23260-23266 (2012).
61. Stone V, Donaldson K. Nanotoxicology: signs of stress. Nat. Nanotechnol. 1(1), 23-24 (2006).
62. Zhang W, Wang C, Li Z, et al. Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism. Adv. Mater. 24(39), 5391-5397 (2012).
63. Li Y, Liu Y, Fu Y, et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials 33(2), 402-411 (2012).
64. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 103(2), 239-252 (2000).
65. Chen G-Y, Yang H-J, Lu C-H, et al. Simultaneous induction of autophagy and Toll-like receptor signaling pathways by graphene oxide. Biomaterials 33(27), 6559-6569 (2012).
66. Akhavan O, Ghaderi E, Esfandiar A. Wrapping bacteria by graphene nanosheets for isolation from environment, reactivation by sonication, and inactivation by near-infrared irradiation. J. Phys. Chem. B 115(19), 6279-6288 (2011).
67. Singh SK, Singh MK, Nayak MK, et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 5(6), 4987-4996 (2011).
68. Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Grácio JJ, Dash D. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano 6(3), 2731-2740 (2012).
69. Huang X, Zhang F, Zhu L, et al. Effect of injection routes on the biodistribution, clearance and tumor uptake of carbon dots. ACS Nano 7(7), 5864-5693 (2013).
70. Yang K, Zhang SA, Zhang GX, Sun XM, Lee ST, Liu ZA. Graphene in mice: ultrahigh In vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10(9), 3318-3323 (2010).
71. Li B, Yang J, Huang Q, et al. Biodistribution and pulmonary toxicity of intratracheally instilled graphene oxide in mice. NPG Asia Mater. 5(4), e44 (2013).
72. Yang K, Wan J, Zhang S, Zhang Y, Lee S-T, Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of pEGylated graphene in mice. ACS Nano 5(1), 516-522 (2010).
73. Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33(7), 2206-2214 (2012).
74. Liu JH, Yang ST, Wang HF, Chang YL, Cao AN, Liu YF. Effect of size and dose on the biodistribution of graphene oxide in mice. Nanomedicine 7(12), 1801-1812 (2012).
75. Hong H, Zhang Y, Engle JW, et al. In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene. Biomaterials 33(16), 4147-4156 (2012).
76. Cornelissen B, Able S, Kersemans V, et al. Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials 34(4), 1146-1154 (2013).
77. Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 49(3), 986-995 (2011).
78. Chen L, Hu P, Zhang L, Huang S, Luo L, Huang C. Toxicity of graphene oxide and multi-walled carbon nanotubes against human cells and zebrafish. Sci. China Chem. 55(10), 2209-2216 (2012).
79. Duch MC, Budinger GRS, Liang YT, et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 11(12), 5201-5207 (2011).
80. Yang K, Gong H, Shi XZ, Wan JM, Zhang YJ, Liu Z. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 34(11), 2787-2795 (2013).
81. Chong Y, Ma Y, Shen H, et al. The in vitro and in vivo toxicity of graphene quantum dots. Biomaterials 35, 5041-5048 (2014).
82. Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3(7), 423-428 (2008).
83. Yan L, Wang YP, Xu X, et al. Can graphene oxide cause damage to eyesight? Chem. Res. Toxicol. 25(6), 1265-1270 (2012).
84. MedlinePlus. www.nlm.nih.gov/medlineplus
85. Wikipedia. http://en.wikipedia.org/wiki/Main-Page
86. Ruiz ON, Fernando KaS, Wang B, et al. Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano 5(10), 8100-8107 (2011).
87. Ali-Boucetta H, Bitounis D, Raveendran-Nair R, Servant A, Van Den Bossche J, Kostarelos K. Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity. Adv. Healthc. Mater. 2(3), 433-441 (2013).
88. Chauhan VP, Stylianopoulos T, Martin JD, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7(6), 383-388 (2012).
89. Chauhan VP, Popovic Z, Chen O, et al. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew. Chem. 123(48), 11619-11622 (2011).
90. Das S, Singh S, Singh V, et al. Oxygenated functional group density on graphene oxide: its effect on cell toxicity. Part. Part. Syst. Char. 30(2), 148-157 (2013).
91. Chng ELK, Pumera M. The toxicity of graphene oxides: dependence on the oxidative methods used. Chemistry 19(25), 8227-8235 (2013).
92. Zhang S, Yang K, Feng L, Liu Z. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon 49(12), 4040-4049 (2011).
93. Akhavan O, Ghaderi E. Graphene nanomesh promises extremely efficient in vivo photothermal therapy. Small 9(21), 3593-3601 (2013).
94. Yang K, Feng L, Hong H, Cai W, Liu Z. Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat. Protoc. 8(12), 2392-2403 (2013).